A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer. A urine-based test may decrease the number of invasive cystoscopies in ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Valar Labs, the developer of computational histology AI tests for predicting response to cancer therapies, announced new data today which is being presented on ...
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe in the months ahead, providing patients and clinicians with ...
A novel urinary test that accurately detects bladder cancer, including early-stage disease, has the potential for enable point-of-care or at-home screening. A novel urine test detected bladder cancer ...
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed ...
A streamlined urine DNA test more accurately detects primary bladder cancer, reducing the need for more invasive cystoscopy, reports The Journal of Molecular Diagnostics Lead investigator Sungwhan An, ...